PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

NCT03044743 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Gastric Carcinoma
Stage IV Nasopharyngeal Carcinoma
T-Cell Lymphoma Stage IV
Stage IV Adult Hodgkin Lymphoma
Stage IV Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Interleukin-2

Sponsor

Yang Yang